Paternal acitretin exposure and the risk of miscarriage and major congenital malformations: A nationwide register-based cohort study - 19/06/20
Doi : 10.1016/j.jaad.2020.01.073
Mia Noergaard, MD a, ⁎ 
, Stine Soendersted Clausen, MD a, Jon Trærup Andersen, MD, PhD a, b
, Stine Soendersted Clausen, MD a, Jon Trærup Andersen, MD, PhD a, b a Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg, Copenhagen, Denmark
b University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark
∗Correspondence to: Mia Noergaard, MD, Department of Clinical Pharmacology, Copenhagen University Hospital at Bispebjerg and Frederiksberg, Bispebjerg Bakke 23, 20C, 2. DK-2400 Copenhagen NV, Denmark.Department of Clinical PharmacologyCopenhagen University Hospital at Bispebjerg and FrederiksbergBispebjerg Bakke 23, 20C, 2CopenhagenNVDK-2400Denmark
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: The cohort study was approved by the Danish Data Protection Agency (2015-41-4309). |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 1
P. 257-259 - juillet 2020 Retour au numéro
Article précédent
- Real-world trends in biologic, oral systemic, and phototherapy in US patients with psoriasis or psoriatic arthritis
- Partik Singh, Jonathan I. Silverberg
- Polycystic ovary syndrome in patients with hair thinning
- Sonya Prasad, Brianna De Souza, Laura J. Burns, Margaret Lippincott, Maryanne M. Senna
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?